#evaluate(de(' #AdditionalMetaTags# '))#
Lyfegen is an independent provider of rebate management software designed for the healthcare industry. Lyfegen solutions are used by health insurances, governments, hospital payers, and pharmaceutical companies around the globe to dramatically reduce the administrative burden of managing complex drug pricing agreements and to optimize rebates and get better value from those agreements. Lyfegen maintains the world’s largest digital repository of innovative drug pricing models and public agreements and offers access to a robust drug pricing simulator designed to dynamically simulate complex drug pricing scenarios to understand full financial impact. Headquartered in Basel, Switzerland, the company was founded in 2018 and has a market presence in Europe, North America, and the Middle East.
TX Ventures leads CHF 5 million round at Lyfegen (startupticker.ch)
Lyfegen raises CHF 5M to scale drug rebate platform globally (venturelab.swiss)
Five startups awarded SEF.Growth High Potential Label (startupticker.ch)
Swiss Delegation to Helsinki to demonstrate their innovation prowess (startupticker.ch)
Innosuisse Scale-up Coaching programme to boost 17 start-ups (startupticker.ch)
Venture Leaders Technology roadshow: Showcasing Swiss innovation in Silicon Valley (venturelab.swiss)
Lyfegen: Meet the Venture Leader Technology pioneering value-based contracting in healthcare (venturelab.swiss)
The road to Silicon Valley: The Venture Leaders Technology 2023 kick off their roadshow (venturelab.swiss)
Swiss startups accelerate precision medicine and value-based healthcare (startupticker.ch)
Ten technology startups brace for Silicon Valley (startupticker.ch)
Swiss National Startup Team 2023: 10 technology startups selected to showcase Swiss innovation in Silicon Valley (venturelab.swiss)
Established companies rely on Swiss startups (startupticker.ch)
Lyfegen secures $8 million to drive down drug costs (startupticker.ch)
Krankenversicherer setzen bei Digitalisierung auf Startups (startupticker.ch)
Deeptech start-ups selected for Venture Day Zurich (startupticker.ch)
Johnson & Johnson relies on Lyfegen? (startupticker.ch)
C-suite managers for Swiss startups (startupticker.ch)
Swiss Startups maintain track record of winning awards (startupticker.ch)
Third InnoPeaks Cohort announced (startupticker.ch)
Additional CHF 2 million for Lyfegen (startupticker.ch)
Lyfegen Raises $8 Million to Drive Down Drug Costs and Help Patients Access Life-Saving Medications